These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6108369)
21. Genetic control of serum antibody responses of inbred mice to type 1 and type 2 fimbriae from Actinomyces viscosus T14V. Haber J; Grinnell CM; Beem JE; Clark WB Infect Immun; 1991 Jul; 59(7):2364-9. PubMed ID: 1675628 [TBL] [Abstract][Full Text] [Related]
22. Analysis of the serum antibody responses to type 1 and type 2 fimbriae in mice immunized with Actinomyces viscosus T14V. Haber J; Grinnell C J Periodontal Res; 1989 Mar; 24(2):81-7. PubMed ID: 2566672 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae. Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255 [TBL] [Abstract][Full Text] [Related]
24. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae. Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012 [TBL] [Abstract][Full Text] [Related]
25. Lactose-reversible coaggregation between oral actinomycetes and Streptococcus sanguis. Kolenbrander PE; Williams BL Infect Immun; 1981 Jul; 33(1):95-102. PubMed ID: 7263074 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a galactose-specific lectin from Actinomyces viscosus by a model aggregation system. Heeb MJ; Costello AH; Gabriel O Infect Immun; 1982 Dec; 38(3):993-1002. PubMed ID: 6185429 [TBL] [Abstract][Full Text] [Related]
27. Co-adhesion of oral microbial pairs under flow in the presence of saliva and lactose. Bos R; van der Mei HC; Busscher HJ J Dent Res; 1996 Feb; 75(2):809-15. PubMed ID: 8655779 [TBL] [Abstract][Full Text] [Related]
28. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae. Clark WB; Wheeler TT; Cisar JO Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143 [TBL] [Abstract][Full Text] [Related]
29. Actinomyces viscosus fibril antigens detected by immunogold electron microscopy. Ellen RP; Buivids IA; Simardone JR Infect Immun; 1989 Apr; 57(4):1327-31. PubMed ID: 2564376 [TBL] [Abstract][Full Text] [Related]
30. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Cisar JO; Kolenbrander PE; McIntire FC Infect Immun; 1979 Jun; 24(3):742-52. PubMed ID: 468376 [TBL] [Abstract][Full Text] [Related]
31. Stimulation of superoxide and lactoferrin release from polymorphonuclear leukocytes by the type 2 fimbrial lectin of Actinomyces viscosus T14V. Sandberg AL; Mudrick LL; Cisar JO; Metcalf JA; Malech HL Infect Immun; 1988 Jan; 56(1):267-9. PubMed ID: 2891619 [TBL] [Abstract][Full Text] [Related]
39. Chemical and immunological comparison of surface fibrils of strains representing six taxonomic groups of Actinomyces viscosus and Actinomyces naeslundii. Masuda N; Ellen RP; Fillery ED; Grove DA Infect Immun; 1983 Mar; 39(3):1325-33. PubMed ID: 6188696 [TBL] [Abstract][Full Text] [Related]
40. Kinetics of lactose-reversible coadhesion of Actinomyces naeslundii WVU 398A and Streptococcus oralis 34 on the surface of hexadecane droplets. Ellen RP; Veisman H; Buivids IA; Rosenberg M Oral Microbiol Immunol; 1994 Dec; 9(6):364-71. PubMed ID: 7870472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]